ClinicalTrials.gg
RecruitingNCT06635187ORARUpdated Oct 10, 2024

ORal-motor Assessment and Rehabilitation Mobile App (ORAR App)

An observational study in Stroke and Oral Motor Functions, sponsored by The Hong Kong Polytechnic University. Recruiting at 1 site in Hong Kong. Open to participants aged 20 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-10.

Sponsored by The Hong Kong Polytechnic University · Observational

From the registry’s dates

  • Started May 2024; still recruiting 2 years 5 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
200
Ages
20 Years to 85 Years
Sex
All
01

Study summary

The goal of this study is to set up a database of oral-motor and speech functions of post-stroke patients in Hong Kong via an artificial intelligence-powered mobile-health application. The main study objectives are:

  1. To establish an image database of oral-facial movements of neurologically healthy adults and adult stroke patients in Hong Kong.
  2. To evaluate the oral-motor functions of neurologically healthy adults and stroke patients via instrumental and behavioral assessment.
  3. To investigate the correlation between image-based analysis of oral-facial functions and instrumental evaluations and subjective judgment by the speech-language therapist.
02

Conditions studied

  • Stroke
  • Oral Motor Functions

Browse trials for

Keywords

  • Mobile App
  • Stroke
  • Oral Motor functions
  • Rehabilitation
  • artificial intelligence
  • speech
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's planned enrollment of 200 is above the median of 160 across 1,729 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 676 studies on the registry; 254 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Medically stable stroke patients and neurologically health adults aged between 20-85 years will be recruited.

Eligibility criteria

For Neurologically healthy adults,

Inclusion Criteria:

  1. age between 20 and 85 years old;
  2. no severe systemic diseases such as uncontrolled diabetes, cerebrovascular diseases, head and neck tumors, or neurological disorders;
  3. not undergoing radiation therapy or chemotherapy;
  4. normal or corrected-to-normal vision and hearing; and
  5. fluent Cantonese speakers

Exclusion Criteria:

1) participants who are unable to sign the "Informed Consent Form" due to cognitive impairments

For stroke patients,

Inclusion Criteria:

  1. age between 20 and 85 years old;
  2. a history of stroke;
  3. not undergoing radiation therapy or chemotherapy;
  4. normal or corrected-to-normal vision and hearing;
  5. premorbid fluent Cantonese speakers; and
  6. able to follow simple commands.

Exclusion Criteria:

  1. individuals currently on non-oral feeding; and
  2. participants who are unable to sign the "Informed Consent Form" due to cognitive impairments
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
200 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Stroke patients

    Adult stroke patients will be recruited to undergo a series of examinations on oral-motor and speech functions.

    Diagnostic Test: Speech and swallowing assessment

  • Control group

    Neurologically healthy adults residing in Hong Kong will undergo the same set of assessments and procedures as the stroke patient group.

    Diagnostic Test: Speech and swallowing assessment

Interventions

  • Diagnostic testSpeech and swallowing assessment

    This is an observational study in which post-stroke patients will undergo a series of assessments tapping oral-motor and speech functions. Both behavioral and instrumental examinations will be used. Their performance will be captured via an artificial intelligence(AI)-powered mobile health application. The relation between the oral/speech-motor movements captured by the app and their performance as measured via instruments/behavioral means will be investigated.

06

What researchers measure

Primary outcomes

  1. Diadochokinetic (DDK) rate of alternating and sequential labial, alveolar and velar plosive sounds

    Participants will be asked to produce /pa/, /ta/, and /ka/ as quick as possible in 10 seconds as alternating motion rate and /pataka/ in 10 seconds as sequential motion rate.

    Time frame: 2-hr assessment

  2. Tongue strength endurance measured by tongue pressure sensor (model: TPM-02, JMS, Hiroshima, Japan)

    Tongue endurance is defined as the time it takes to reach 60 % or more of maximum tongue strength. Three trials were performed, while the average duration (in terms of seconds) taken by the tongue pressure sensor will be used to determine tongue function.

    Time frame: 2-hr assessment

  3. Mastication efficiency as measured via glucose sensor (model: GS-II, GC Corporation, Toyko, Japan)

    A 2-gram gummy jelly that comes with the glucose sensor will be put into the mouth, and the subject will be asked to chew the gummy for 20 seconds. Afterward, everything will be discharged into a paper cup, and the resultant filtrate will be examined quantitatively via the glucose sensor. Mastication efficiency will be illustrated in terms of milliliter per deciliter (mL/dL).

    Time frame: 2-hr assessment

  4. Occlusal force as measured via the occulsal pressure measurement film (model: Dental Prescale II, GC Corporation, Toyko, Japan)

    An occlusal pressure measurement film will be put into the oral cavity and s/he will be asked to close the jaw firmly for 2-3 seconds. The film will be scanned by a scanner (model: GT-X830, Epson, Nagano, Japan) and analyzed by a software called Bite force analyzer manufactured by the GC Corporation. Occlusal force will be represented in Newton.

    Time frame: 2-hr assessment

  5. Maximum tongue strength measured by tongue pressure sensor (model: TPM-02, JMS, Hiroshima, Japan)

    Participants will be asked to press the bulb of the tongue pressure sensor with the anterior part of the tongue as hard as they can. The maximum tongue strength in kilopascal (KPa) will be measured by the sensor.

    Time frame: 2-hr assessment

Secondary outcomes

  1. The Chinese version of the Oral Health Impact Profile-14 (OHIP-14) questionnaire to assess oral health-related quality of life.

    Participants will be asked to give ratings on the questionnaire based on a 5-point Likert scale. Lower scores represent better oral condition-related quality of life. The maximum and minimum scores are 56 and 0, respectively.

    Time frame: 2-hr assessment

  2. Chinese version of Eating Assessment Tool (EAT-10) questionnaire as a self-reported outcome instrument on swallowing functions

    The questionnaire consists of 10 questions, and participants will be asked to evaluate their swallowing functions based on a 5-point Likert scale (0=not at all; 4=very much). Lower scores reflect better swallowing performance. Maximum and minimal scores are 40 and 0, respectively.

    Time frame: 2-hr assessment

07

Study locations

1 of 1 sites recruiting
  • Speech Therapy Unit, Room 701, Block EF, The Hong Kong Polytechnic Unviersity
    Hong Kong, Hong Kong 852, Hong Kong
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The dataset will be available on an open-access repository such as OSF.

Supporting information: Study protocol, Informed consent form

Time frame: 5 years upon the project end date

Access criteria: Open access to all people

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Mar 2027, 34 months after the start.

Of 787 non-industry observational studies under Stroke, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 101. This study's planned 34 months is below that.

Counting every sponsor, half of 833 studies reached it within 41 months; a quarter within 18 and three quarters within 92.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2024
First posted
Oct 10, 2024
StartActual
May 1, 2024
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Oct 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06635187
Responsible party
Sponsor
First posted
Oct 10, 2024
Start date
May 1, 2024
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Oct 10, 2024

Study contacts

Winsy Wing Sze Wong, PhD
Contact
winsyws.wong@polyu.edu.hk
852-3400-3117
Winsy Wing Sze Wong, PhD
principal investigator · The Hong Kong Polytechnic University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion